Leadership

Jonathan Dinman, Ph.D.

Director, Institute for Bioscience and Biotechnology Research, Professor, University of Maryland Department of Cell Biology and Molecular Genetics

Dr. Jonathan Dinman is the Director of the Institute for Bioscience and Biotechnology Research (IBBR) and a Professor in the Department of Cell Biology and Molecular Genetics at the University of Maryland, College Park. He has taught virology, RNA Biology and a University Honors class exploring the influence of globalization and climate change on infectious diseases. He previously served as Director of the MOCB graduate program, Chair of the Department of Cell Biology and Molecular Genetics and was a Fellow in both the NSF ADVANCE Program and the Honors College. Dr. Dinman earned his B.A. from Oberlin College in 1980, his Ph.D. in Immunology and Infectious Diseases from Johns Hopkins School of Hygiene and Public Health in 1988, and completed a postdoctoral fellowship at the National Institutes of Health from 1988 to 1995. His research focuses on the control of gene expression at the level of protein synthesis, with emphasis on virology, ribosome structure/function relationships, and human disease.

David Weber, Ph.D.

Associate Director, Institute for Bioscience and Biotechnology Research, Professor, University of Maryland School of Medicine, Department of Biochemistry and Molecular Biology

Dr. David Weber is the Associate Director of the Institute for Bioscience and Biotechnology Research (IBBR) and Director of the Center for Biomolecular Therapeutics (CBT). He is also a Distinguished University Professor in the Department of Biochemistry and Molecular Biology at the University of Maryland School of Medicine. He previously served as Director of the UMB NMR Center and Director of Graduate Education for the Joint Program in Biochemistry & Molecular Biology at UMB. Dr. Weber earned his B.S. from Muhlenberg College in 1984, his Ph.D. in Chemistry from University of North Carolina, Chapel Hill in 1988, and completed a postdoctoral fellowship at Johns Hopkins School of Medicine from 1988 to 1992. His research focuses on understanding structure/function relationships in healthy and disease states using structural biology (NMR, X-ray, CryoEM) and other biophysical methods for therapeutic development through the IBBR and CBT.